BACKGROUND: Iodine as a micronutrient is mandatory for thyroid hormone production and inadequate iodine intakes during pregnancy may result in varying degrees of hypothyroidism affecting pregnancy outcomes adversely. The aim of this study was to evaluate nutritional status and its effects on thyroid function in pregnant women during all trimesters of pregnancy. SUBJECTS/METHODS: In this cohort study, we assessed a total of 203 pregnant women in the first trimester of pregnancy and followed them in the second and third trimesters. They were divided into two groups, group I with urinary iodine excretion (UIE) o150 mg/l, and group II with UIE X150 mg/l. Serum samples from women were assayed for levels of total T4, T3, FT4I and thyroidstimulating hormone (TSH), thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) only once in each trimester. Urinary iodine concentration was measured three times and the median was considered as UIE in the first trimester, but it was measured only once in the second and third trimesters. RESULTS: The median inter quartile ranges of urinary iodine were 218 (150-276) mg/l, 160 (106-260) mg/l and 145 (88-225) mg/l in the three trimesters of pregnancy, respectively; UIEo150 was observed in 48 (24.1%), 90 (44.8%) and 103 (52.3%) of pregnant women in the three trimesters of pregnancy, respectively. The median (range) of TSH was 1.7 (0.9-2.7) mIU/l, 1.9(1.2-2.7) mIU/l and 1.8 (1.1-2.8) mIU/l in the three trimesters of pregnancy, respectively. There was no correlation between UIE, TSH, TT4, FT4I, T3 and TPOAb in the first and second trimesters, but there was a weak correlation between UIE, TSH, T3 and TgAb in the third trimester. CONCLUSION: In our cohort of pregnant women the iodine intakes were sufficient, and no correlation between urinary iodine concentration and thyroid function tests was found.
INTRODUCTION
Iodine as a micronutrient is mandatory for thyroid hormone production during pregnancy. Inadequate iodine intake may result in either varying degrees of hypothyroidism that affects the pregnancy outcomes seriously 1 or causes fetal iodine deficiency that harms neurocognitive development of the growing fetus. 2 During pregnancy, as there are many physiologic changes in thyroidal hormone production, the amount of iodine intake should be increased to meet the higher demands needed for thyroxine production (T4), for transfer of iodine to the fetus 3 and for increased renal iodine clearance by the mother. 4, 5 Overall the Islamic republic of Iran has been defined as an iodine sufficient area, by the World Health Organization (WHO) criteria, since 2000. 6 Adequate iodine nutrition status in a general population may not always translate to its adequacy in pregnant women; 7 hence, to assure sufficient iodine intake in pregnant women, urinary iodine excretion (UIE) needs to be assessed in this population by measuring the urinary iodine levels. The currently recommended intake of iodine through universal salt iodization may not be adequate for pregnant and lactating women, and supplementation during pregnancy and lactation should be further considered, based on current recommendations. 8, 9 Azizi et al. [8] [9] [10] have reported that median UIE in the first and second trimesters although similar, were marginally higher than in the third trimester. 10 The median UIE revealed a decreasing pattern from adequate levels in the first trimester to inadequate values in the third trimester of pregnancy. 10 Rostami et al. 11 have also shown that median UIE during pregnancy in Urmia, West Azerbaijan is obviously lower than that previously reported for other country regions with adequate iodine status. As a result, more iodine is needed to maintain adequate iodine stores during gestation. Li et al. 12 also showed there was a trend toward hypothyroidism in some pregnant women, although their iodine nutritional status during gestation was appropriate. Iodine deficiency affects fetal neurocognitive development either per se or induces hypothyroidism or hypothyroxinemia that predisposes the fetus to adverse pregnancy outcomes. 13 Controversy exists regarding the correlation between UIE and mother thyroid function tests during pregnancy. 14 We conducted this study to evaluate iodine nutritional status and its effects on thyroid function in pregnant women during all the three trimesters of pregnancy.
MATERIAL AND METHODS
This cohort study, performed in Tehran, an area of iodine sufficiency, included a total of 203 pregnant women referred to the mother and child health-care clinics of two general hospitals of Tehran. Subjects were consecutively recruited from November 2004 to November 2006. Written informed consent was obtained from all subjects. Pregnant women were recruited in the first trimester and then were followed during second and third trimesters. Women with known thyroid disease were excluded from the study. We specifically recruited women who were not taking iodine supplementation. Serum samples of all participants were assessed for concentrations of thyroid-stimulating hormone (TSH), T3, T4, free T4 Index (FT4I), thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) in each trimester. Data collection for urinary iodine concentrations was missed in four individuals in the first trimester and in three and six individuals in the second and third trimesters, respectively. Three separate spot urine samples were obtained from each pregnant mother during the first trimester and the median was considered as the UIE in the first trimester. UIE was measured just once in the second and third trimesters. The median UIE of three trimesters was considered and pregnant women were divided into two groups according to WHO recommendations: 15 Group I with median UIEo150 mg/l and group II with median UIEX150 mg/l. Casual morning urine samples (5-10 ml) were collected from the participants and were kept frozen at -20 1C until assayed for urine iodine concentration at the end of the study; urinary iodine concentration was measured by the modified Sandell-Kolthoff digestion method. 16 Results are given as microgram of iodine per liter of urine (mg/l). Intra-assay coefficients of variation (CV) of the UIE measurement method for concentrations of 3.5, 15 and 38 mg/l were 11.2, 8.2 and 9.4%, respectively, whereas inter-assay CVs for the same concentrations were 12.5, 8.9 and 10.3%, respectively.
Serum total T4, FT4I and T3 were measured by the radioimmunoassay method and TSH was evaluated by the immunoenzymometric assay using commercial kits (Izotop, Budapest, Hungray and Orgentec Diagnostic GmbH, Mainz, Germany, respectively, with gamma counter (Wallac Wizard, Wallac Oy, Turku, Finland)). Intra-and inter-assay CVs were 3.3 and 6.2% for T4, 6.7 and 7.8% for T3, 3.8 and 5.8% for FT4 and 3.9 and 7.1% for TSH, respectively. The reference ranges considered for free T4 index (FT4I), total T4, total T3 and TSH were 55-160, 4.5-12.5 mg/dl, 60-181 ng/dl and 0.39 to 4.6 mU/l, respectively. 17 TgAb and TPOAb were measured using enzymoimmuometric assay (EIMA) kits (Orgentec Diagnostica GmbH). Intra-and inter-assay CVs were 2.2 and 4.9% for TgAb and 3.0 and 5.1% for anti-TPO, respectively. The study was approved by the appropriate Human Research Committee of the Shahid Beheshti University of Medical Sciences.
Statistical analysis
The normality of UIE, serum total T4, T3, FT4I, TSH and TPOAb in three trimesters of pregnancy was checked using a histogram and the kolmogrov-Smirnov test. We employed a t-test for comparison of TT4, TT3 and FT4I, and the Mann-Whitney U-test for comparison of TSH between the two groups. Friedman's test or repeated measured test were used for comparing data between three trimesters as appropriate. Data are expressed as mean±s.d., median and inter quartile range (IQR). Correlations between UIE and TSH, TT4, TT3, FT4I, TPOAb and TgAb, were examined using Spearman's rank correlation coefficient, with P-values less than 0.05 being considered significant. All analyses were performed with SPSS software version 20.0 (IBM Corp., Armonk, NY, USA).
RESULTS
A total of 203 pregnant women, aged 25.2±5.0 years, participated in this study. Their mean ± s.d. of gestational age was 12.2 ± 3.7 weeks. All of them had singleton pregnancies.
First trimester
The median (IQR) of urinary iodine was 218 (150-276) mg/l. A total of 48 women (24.1%) had UIEo150 and 151 (76%) had UIEX150 mg/l ( Figure 1) ; UIE levels o100 mg/l, between 100-150 mg/l and 150-250 mg/l and 4250 mg/l were found in 10 (5%), 38 (19.1%), 83 (41.7%) and 68 (34.2%) women, respectively. Fifty (24.6%) and 153 (75.4%) women were euthyroid in groups I and II, respectively; 19 were both euthyroid and had positive TPOAb; median (IQR) UIE was 191 (140-284) mg/l in euthyroid subjects. The median (range) of TSH and mean ± s.d. of TT4, FT4I and TT3 are shown in Table 1 . There were no differences in TSH, TT4, FT4I and TT3 values between the two groups. There were no correlations between UIE, TSH, TT4, FT4I, T3 and TPOAb, but a weak correlation was observed between UIE and TgAb (r ¼ -0.3, P ¼ 0.03).
Second trimester
The median (IQR) urinary iodine was 160 (106-260) mg/l. A total of 90 women (44.8%) had UIEo150, whereas in 111 (55%), it was X150 mg/l ( Figure 1) ; UIE levels o100 mg/l, between 100-150 mg/l and 150-250 mg/l and 4250 mg/l were observed in 46 (22.9%), 44 (21.9%), 52 (25.9%) and 59 (29.4%) of women, respectively. A total of 46 (22.7%) and 157 (77.3%) women were euthyroid in groups I and II, respectively; 20 were both euthyroid and had positive TPOAb. The median (IQR) UIE was 148 (91-228) mg/l in euthyroid subjects. The median (range) of TSH and mean ± s.d. of TT4, FT4I and TT3 are shown in Table 1 . There were no differences in TSH, TT4, FT4I and TT3 values between the two groups. There were no correlations between UIE levels and TSH, TT4, FT4I, T3, TPOAb or TgAb.
Third trimester Median IQR of urinary iodine was 145 (88-225) mg/l; 103 women (52.3%) had UIEo150 and 94 (47.7%) had UIEX150 mg/l (Figure 1) , UIE levels o100 mg/l, between 100-150 mg/l and 150-250 mg/l and 4250 mg/l were observed in 54 (27.4%), 49 (24.9%), 60 (30.5%) and 34 (17.3%) of women, respectively. A total of 46 (22.7%) and 157 (77.3%) women were euthyroid in groups I and II, respectively; 12 pregnant women were both euthyroid and had positive TPOAb. The median (IQR) for UIE was 169 (114-213) mg/l in euthyroid subjects. The median (range) of TSH and mean ± s.d. of TT4, FT4I and TT3 are shown in Table 1 . There were no differences in TSH, TT4, FT4I and TT3 values between the two groups. There were weak correlations between UIE levels and TSH (r ¼ À 0.2, P ¼ 0.01), T3 (r ¼ À 0.2, P ¼ 0.006) and TgAb (r ¼ À 0.2, P ¼ 0.004), but none between TT4, FT4I and TPOAb.
DISCUSSION
To our knowledge this is the first study conducted among pregnant Tehranian women, measuring UIE and maternal thyroid function in the three trimesters of pregnancy. Median UIE levels in our cohort of pregnant women were 218, 160 and 145 mg/l, 1st trimester 2nd trimester 3rd trimester Figure 1 . Urinary iodine excretion in groups I and II (UIEo150 mg/l and UIEX150 mg/l, respectively) during the first, second and third trimesters of pregnancy.
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which is above 150 mg/l, the currently recommended threshold, in the first and second trimesters but slightly lower in the third trimester of pregnancy. We did not find any association between urinary iodine and thyroid function tests. Dietary iodine requirements are increased in pregnancy owing to increased maternal demand during this period. Before 20 weeks gestation the increased demand is mostly due to increased maternal thyroid hormone production, inactivation of thyroid hormones by placental deiodinase and increased UIE, 18 but after this period, iodine is needed mostly for fetal hormone production. 19 Iodine deficiency during pregnancy can cause maternal and fetal hypothyroidism and impair neurological development in the fetus. 20 Recommended dietary allowances of iodine, published by the International Council for Control of Iodine Deficiency Disorders and WHO, are 250 mg/d for pregnant and lactating women. 21 For many years hence, it was believed that iodine deficiency in the Iranian population was not a threat; 6 the present study showed our pregnant women to be above the threshold of the definition of iodine sufficiency especially in the first and second trimesters, that is, their median UIEs ranged between 150-249 mg/l. 21 Recently, Brucker-Davis et al. 14 reported the median UIE to be 116 mg/l in early pregnancy and showed mild iodine deficiency in their population. In addition, the median urinary iodine concentration was reported to be 81 mg/l in pregnant women, residents in western Sydney indicating overall a high prevalence of iodine deficiency. 22 Recently, Rostami et al.
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revealed that overall median UIE in pregnant residents of Urmia, in I.R. Iran, was 93.7 mg/l; that was 73.5 mg/l in first and 114 mg/l. The NHANES survey showed 35.5% of pregnant women suffer from mild iodine deficiency with urinary iodine levels below 100 mg/l.
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As a part of physiologic changes, glomerular filtration rate increases during the first trimester of pregnancy; we, hence, expected to observe better iodine status during this trimester compared with the other two. In the current study, no correlation was found between UIE and maternal thyroid tests in all trimesters, similar to the recent findings of Brucker-Davis 14 who also found no such correlation in euthyroid pregnant women in early pregnancy; Hieronimus 24 also reported this lack of correlation during the third trimester among pregnant women living in an iodine insufficient area. Our results are also similar to those reported by Fuse et al. 25 who found no correlation between UIE and thyroid function parameters in Japanese pregnant women, in an iodine sufficient area. The results of trials that have focused on the effect of the treatment of iodine deficiency on thyroid function tests vary. One trial showed iodized salt consumed by healthy iodine-deficient pregnant women (median UIE 31-37 mg/l) during the first trimester of pregnancy had no effect on maternal serum TSH level; 26 in contrast, a study of randomized pregnant Danish women receiving either 200 mg iodine or placebo, showed maternal thyroglobulin and TSH to be significantly lower in the treated group, whereas no significant differences were found between groups comparing maternal T4, T3 and free T4. 27 In the Glinoer et al. 28 study, Belgian pregnant women were given iodine supplements, but in those with iodine deficiency with median UIE 36 mg/l, treatment had no significant effect on maternal T3, FT4 and T3/T4 ratio; the treatment group, however, had lower TSH and Tg concentrations compared with controls. Good iodine nutritional status at the beginning of pregnancy is essential for maintaining proper thyroid function in the mother throughout the gestation period; but in this study, we found adequacy of iodine intake during pregnancy and having a successful iodization program in our country by which the amount of iodized salt consumed by pregnant women is sufficient during the gestational period. Even with just a few individuals suffering from iodine deficiency, we found no evidence of disturbed thyroid function in this group. As Iran is among countries with a longstanding, well-established universal salt iodination program where iodine sufficiency has been achieved, and there is no emphasis on pregnant women using multivitamin and/or mineral tablets (even those specifically prepared for the needs of pregnancy and containing iodine supplements), no such firm decisions have yet been made by the medical community and public health authorities.
One of the limitations of this study is that, we measured UIC at the end of the study, therefore the group with median urinary iodine concentration o150 mg/l in each trimester has not been picked up. WHO and UNICEF recommend iodine supplementation for pregnant and lactating women in countries where households do not have access to iodized salt. Countries were households have access to iodized salt should make efforts to either accelerate salt iodization or to assess the feasibility of increasing iodine intake in a supplemental form or iodine-fortified foods in the most susceptible groups. Iran is among countries with a longstanding, well-established universal salt iodination program where iodine sufficiency has been achieved, and the national IDD committee has not recommended iodine supplementation in pregnant women. In addition, iodine concentrations in a spot or casual urine sample cannot be used to diagnose iodine deficiency, as the UI concentration may vary up to three-fold in an individual during a day. Hence, it is necessary to collect repeated urine samples from an individual over a specified period of time and estimate the median or average, in order to evaluate their precise iodine status.
In conclusion, iodine intakes assessed by UIE in our cohort of pregnant women were regarded as sufficient based on the WHO criteria and no correlation was found between urinary iodine concentration and thyroid function tests.
